Simon Berry - Newcells

Retinal platform

An in vitro, light responsive, retinal model for accurate predictions of in vivo outcomes you can have confidence in.

aProximateTM

Kidney platform

The most advanced near-physiological high throughput kidney proximal tubule cells (PTC) model to investigate drug transport modalities in vitro.

Lung epithelia model

Lung model

A model to investigate airway physiology, viral infection, drug safety and environmental impacts on lung airway epithelia.

Sinusoid iPSC-derived Liver model

Liver model

We are developing a model of liver sinusoid derived from human induced pluripotent stem cells (iPSC).

Simon Berry

Finance Director

Simon has over 15 years’ experience working in senior finance roles in a variety of companies and industries including financial services, manufacturing, retail, wholesale and e-commerce . Originally from Newcastle-upon-Tyne Simon qualified as a chartered accountant with PwC, following his degree in Accounting and Financial Management at Sheffield University. Simon spent several years working in investment banking with Citigroup in London, then returned to his native North East where he has led and managed finance functions in private-equity owned, publicly listed and privately owned businesses such as Akzo Nobel, Attends Healthcare and Swarovski Group. Simon has a particular passion for working closely with management teams in fast growing SMEs, developing finance teams and functions to improve business performance and deliver the business strategy. Simon joined Newcells in July 2021 and is excited to be working with the innovative and talented team to help the company go from strength to strength!

Favourite Quotation: “Everything that exists in your life does so because of two things: something you did or something you didn’t do” – Albert Einstein